Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor.
about
Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2.Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits.Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteinsExpression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation.Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitorsPhosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitorNot so pseudo: the evolutionary history of protein phosphatase 1 regulatory subunit 2 and related pseudogenesDual involvement of G-substrate in motor learning revealed by gene deletion.Purkinje cell-specific knockout of the protein phosphatase PP2B impairs potentiation and cerebellar motor learning.Protein kinase C activation decreases peripheral actin network density and increases central nonmuscle myosin II contractility in neuronal growth conesOccurrence of cGMP/nitric oxide-sensitive store-operated calcium entry in fibroblasts and its effect on matrix metalloproteinase secretion.Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1).Role of CPI-17 in the regulation of endothelial cytoskeleton.Protein phosphatase 2A inhibition induces cerebellar long-term depression and declustering of synaptic AMPA receptor.Lack of kinase regulation of canonical transient receptor potential 3 (TRPC3) channel-dependent currents in cerebellar Purkinje cells.An efficient method for the long-term and specific expression of exogenous cDNAs in cultured Purkinje neurons.A functional interaction between CPI-17 and RACK1 proteins in bronchial smooth muscle cellsGATA-6 and NF-κB activate CPI-17 gene transcription and regulate Ca2+ sensitization of smooth muscle contractionSynaptic signalling in cerebellar plasticity.Role of CPI-17 in restoring skin homoeostasis in cutaneous field of cancerization: effects of topical application of a film-forming medical device containing photolyase and UV filters.Stochastic Induction of Long-Term Potentiation and Long-Term DepressionDiversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction.Putative protein partners for the human CPI-17 protein revealed by bacterial two-hybrid screening.MAG-EPA and 17,18-EpETE target cytoplasmic signalling pathways to reduce short-term airway hyperresponsiveness.Actions downstream of cyclic GMP/protein kinase G can reverse protein kinase C-mediated phosphorylation of CPI-17 and Ca²⁺ sensitization in smooth muscle.An NMDA receptor/nitric oxide cascade is involved in cerebellar LTD but is not localized to the parallel fiber terminal.Protein phosphatase-1M and Rho-kinase affect exocytosis from cortical synaptosomes and influence neurotransmission at a glutamatergic giant synapse of the rat auditory system.Computational simulation for interactions of nano-molecules: The phospho-pivot modeling algorithm for prediction of interactions between a phospho-protein and its receptorPhospho-Pivot Modeling Predicts Specific Interactions of Protein Phosphatase-1 with a Phospho-Inhibitor Protein CPI-17
P2860
Q24539100-5987C39B-6263-457E-83D4-2DFCC4490E2EQ24562656-E5CB7CEA-B18D-40E7-8FC1-AD1D04C1B635Q24563922-66E0B7ED-0445-4C88-9C99-6DB34B1ECBFEQ24603483-E4BA4CED-EBDF-4539-B648-EE54943E21C3Q24644388-A374B5FA-D965-4821-B26F-ED14DD5E86EBQ24644395-0243F696-17AA-414E-BB15-77E8FC60F129Q28661447-7B83A313-179A-4193-9184-55C096D71DCCQ30485991-37E2A1F1-F323-4020-93F3-4C3C46A3EB6CQ30496652-9ED2DF81-8144-4056-AAC2-083D2770964CQ30547068-A304A4D7-A6E7-4B86-A85F-F4C589F63504Q33258695-E45B5297-04B6-47B3-906E-3EE85E04B689Q33719596-FA7C6628-B174-461D-A7EA-EA30F8326AA8Q34331200-14D02E97-9821-4D10-877C-76CB762F750DQ35736454-5E10E823-EA3B-40FC-9DC7-32F974B531CBQ35839011-1F6A9EE5-CB0F-4033-8B85-C5EEA965BBD1Q36124586-174B1D08-3BD5-4952-BD89-74F546E1DF76Q36364609-89C975B3-B854-4232-B5E7-D2A72CEB5078Q36757036-5E2C83DC-B73C-424E-87F2-98BCD563F6AEQ36848973-E6435274-F478-4D71-B6AB-A3E1C2797EEDQ37108899-98540DE6-DA5D-4FBA-AE6A-991759228DA9Q37147896-6C78A7F9-1C0D-4E26-9AA9-88D0C171DA4CQ39162238-F2C24052-8253-4280-897C-44A5241C91B8Q41509166-67ECEF51-A554-4551-9D5F-A2CA693E1AE1Q44241489-C1362E0D-41F9-416C-8D4C-80AC314EB500Q44881093-65A277F8-BD74-451E-9238-4CD191601CD4Q46667755-74A23021-54ED-4875-9994-F93D8F0B19BDQ47362106-7D2F2599-1240-458B-98FC-1F07160C4121Q57464771-5422E0EB-5077-4D94-87F6-155E0FF3898EQ57464775-784EFD9A-6587-4AE5-99D4-602D256EE055
P2860
Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cerebellar long-term synaptic ...... /moesin phosphatase inhibitor.
@ast
Cerebellar long-term synaptic ...... /moesin phosphatase inhibitor.
@en
type
label
Cerebellar long-term synaptic ...... /moesin phosphatase inhibitor.
@ast
Cerebellar long-term synaptic ...... /moesin phosphatase inhibitor.
@en
prefLabel
Cerebellar long-term synaptic ...... /moesin phosphatase inhibitor.
@ast
Cerebellar long-term synaptic ...... /moesin phosphatase inhibitor.
@en
P1433
P1476
Cerebellar long-term synaptic ...... /moesin phosphatase inhibitor.
@en
P2093
David J Linden
David L Brautigan
P304
P356
10.1016/S0896-6273(02)01107-8
P407
P577
2002-12-01T00:00:00Z